CoChat

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index; 63 of the 114 sources its claims cite were checked for support.

Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota

Open access
Bloor, Sarah R., Schutte, Rudolph, Hobson, Anthony R. · 2021 · Microbiology Research

Abstract

Iron deficiency anaemia (IDA) is a worldwide healthcare problem affecting approximately 25% of the global population. The most common IDA treatment is oral iron supplementation, which has been associated with gastrointestinal (GI) side effects such as constipation and bloating. These can result in treatment non-adherence and the persistence of IDA. Intravenous iron does not cause GI side effects, which may be due to the lack of exposure to the intestinal lumen. Luminal iron can cause changes to the gut microbiota, aiding the promotion of pathogenic species and decreasing beneficial protective species. Iron is vital for methanogenic archaea, which rely on iron for growth and metabolism. Increased intestinal methane has been associated with slowing of intestinal transit, constipation, and bloating. Here we explore the literature to understand a potential link between iron and methanogenesis as a novel way to understand the mechanism of oral iron supplementation induced GI side effects.

Overview

CoChat Summary

TL;DR

This narrative review argues that oral iron supplementation causes gastrointestinal side effects partly through unabsorbed luminal iron altering the gut microbiota and potentially promoting methanogenic archaea and methane production, which is linked to constipation and slow transit. It synthesizes evidence on iron absorption, inflammation, microbiota, and methane-modulating strategies, but the mechanism remains unproven.

Key findings

  • IDA affects up to 25% of the worldwide population (~2 billion people); in the U.K. it costs the NHS £55.48 million and causes 57,000 hospital admissions annually. Oral iron causes GI side effects in up to 60% of users, and up to 50% do not follow treatment; IV iron has lower rates of nausea (1.6% vs. 4.9%), vomiting (1.0% vs. 6.8%), abdominal pain (1.3% vs. 7.9%), and diarrhoea (0.9% vs. 8.3%).
  • Recommended ferrous sulphate 200 mg (65 mg elemental iron) two or three times daily can deliver up to 195 mg elemental iron/day, but only up to 25 mg/day can be absorbed under extreme iron deficiency; the typical adult diet contains 8–15 mg iron/day, with 1–2 mg absorbed daily.
  • Iron supplementation/fortification shifts the gut microbiota: increased enteropathogens such as *Salmonella*, *Shigella*, and *Escherichia coli*, and decreased *Lactobacillus*; Kenyan infants showed increased *Enterobacteriaceae* and decreased *Lactobacillus* and *Bifidobacterium*. Iron fortification (~8 mg/day) in African children produced similar adverse shifts.
  • The authors hypothesize that iron supports methanogenic species and methanogenesis; methane is associated with slower intestinal transit and constipation. Methanogens are believed present in 30–50% of the population, and potential methane-reducing options discussed include rifaximin plus neomycin, lovastatin, Atrantil (88% response in constipation-predominant IBS), *L. reuteri*, multistrain probiotics (reduced whole gut transit by 13.75 h), and seaweed in cattle (up to 70–95% methane reduction), though human evidence is lacking.

Methods

  • Narrative review of the literature; no primary data collection, systematic search strategy, or meta-analysis is reported.
  • Synthesizes human, animal, in vitro, and environmental/microbiology evidence on iron absorption and dosing, iron-induced oxidative stress and inflammation, gut microbiota changes, methanogens and methanogenesis, and methane-modulating treatments.
  • Main output is a hypothesis linking oral iron-induced GI side effects to iron-driven changes in the gut microbiota and methanogenic archaea/methane production.

Limitations

  • Stated: the mechanism by which oral iron supplements cause adverse GI effects is unknown; long-term effects of iron supplementation/fortification on the gut microbiota are unknown; whether methane causes or is a consequence of constipation is uncertain; there is no evidence for seaweed reducing methane in humans; and besides antibiotics, little evidence supports effective methane reduction or methanogen eradication.
  • Evident: as a narrative review, it lacks systematic search, inclusion criteria, and quality appraisal; the central iron–methanogen–GI symptom link is hypothesis-generating and not directly tested in the paper.
  • Evident: many cited findings come from non-human contexts (e.g., cattle, environmental methanogenesis) or specific populations (infants, IBD patients), limiting generalizability.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/microbiolres12020033

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

48 Valid · 5 Not valid · 30 Not checked · 15 Own results and interpretations

34 more claims · 15 with their cited sources checked

Create a free account to see all 98 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 43
  • Probably not a substantial claim. 21

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 98 references

Research works printed but not linked: 3

  1. Ojetti, 2017, Reuteri in Methane Producer Constipated Patients, Eur. Rev. Med. Pharmacol. Sci., 21, 1702
  2. Deere, T.M., Lessner, F.H., Duin, E.C., and Lessner, D.J. (2017, January 24–28). Building an ancient cofactor: Iron-sulfur cluster biogenesis in methanogenic archaea. 1. Proceedings of the Diverse Life and its Detection on Different Worlds, Mesa, AZ, USA.
  3. Ramakrishnan, 2017, Investigation of Lovastatin, the Anti-Hypercholesterolemia Drug Molecule from Three Oyster Mushroom Species, Int. J. Biomed. Clin. Sci., 2, 26

Cited by

See all 117

Metadata

Authors
Bloor, S. R., Schutte, R., & Hobson, A. R.
Affiliations
  • Anglia Ruskin University (GB)
  • Functional Gut Diagnostics, Manchester M2 4NG, UK
Corresponding author
Bloor, Sarah R.
Venue
Microbiology Research
Publisher
MDPI AG
Published
2021-06-12
Volume
12
Issue
2
Pages
491-502
ISSN
  • 2036-7473 (ISSN-L)
  • 2036-7481
OpenAlex
W3166534408
Cited by
117
References
93
Citations by year
2026: 37 · 2025: 28 · 2024: 18 · 2023: 23 · 2022: 8 · 2021: 3
FWCI
4.08
Type
journal article
Language
en
Open access
Locations
  • Microbiology Research (publishedVersion, cc-by)
  • Anglia Ruskin Research Online (Anglia Ruskin University) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
oral iron supplementation, iron deficiency anemia, gastrointestinal adverse effects, constipation, bloating, gut microbiota, methanogenesis, methanogenic archaea, intestinal transit, medication adherence, intravenous iron

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota. https://app.cochat.ai/papers/10.3390/microbiolres12020033
The paper
Bloor, S. R., Schutte, R., & Hobson, A. R. (2021). Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota. Microbiology Research. https://doi.org/10.3390/microbiolres12020033

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.